Related references
Note: Only part of the references are listed.Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320
Thomas B. Kjeldsen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial
Harpreet S. Bajaj et al.
DIABETES CARE (2021)
Insulin Icodec: An Insulin Analog Suited for Once-Weekly Dosing in Type 2 Diabetes
Ulrike Hovelmann et al.
DIABETES (2020)
Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
Julio Rosenstock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The Discovery and Development of Liraglutide and Semaglutide
Lotte Bjerre Knudsen et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial
Inge B. Halberg et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Identification of barriers to insulin therapy and approaches to overcoming them
David Russell-Jones et al.
DIABETES OBESITY & METABOLISM (2018)
Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?
P. D. Home
DIABETES OBESITY & METABOLISM (2015)
Glycaemic control of Type1 diabetes in clinical practice early in the 21st century: an international comparison
J. A. McKnight et al.
DIABETIC MEDICINE (2015)
Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc)
Jennifer M. Polinski et al.
BMC ENDOCRINE DISORDERS (2015)
Comparative effectiveness of vildagliptin in combination with other oral anti-diabetes agents in usual-care conditions: the EDGE-Latin America study
Carlos O. Mendivil et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
Albumin as a versatile platform for drug half-life extension
Darrell Sleep et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Albumin-drug interaction and its clinical implication
Keishi Yamasaki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Clinical outcomes after 24 months of insulin therapy in patients with type 2 diabetes in five countries: results from the TREAT study
A. Oguz et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study
M. Peyrot et al.
DIABETIC MEDICINE (2012)
Systematic Evaluation of the Metabolic to Mitogenic Potency Ratio for B10-Substituted Insulin Analogues
Tine Glendorf et al.
PLOS ONE (2012)
Molecular Characterisation of Long-Acting Insulin Analogues in Comparison with Human Insulin, IGF-1 and Insulin X10
Bo F. Hansen et al.
PLOS ONE (2012)
Patient perspectives on once-weekly medications for diabetes
W. H. Polonsky et al.
DIABETES OBESITY & METABOLISM (2011)
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
Mark R. Sommerfeld et al.
PLOS ONE (2010)
Albumin as Fatty Acid Transporter
Ger J. van der Vusse
DRUG METABOLISM AND PHARMACOKINETICS (2009)
MCF-7 human mammary adenocarcinoma cells exhibit augmented responses to human insulin on a collagen IV surface
Nicolai Listov-Saabye et al.
JOURNAL OF APPLIED TOXICOLOGY (2009)
Identification of high affinity fatty acid binding sites on human serum albumin by MM-PBSA method
Shin-Ichi Fujiwara et al.
BIOPHYSICAL JOURNAL (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses
Maja Jensen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A luminescent oxygen channeling immunoassay for the determination of insulin in human plasma
Fritz Poulsen et al.
JOURNAL OF BIOMOLECULAR SCREENING (2007)
The relation between intermittent dosing and adherence: Preliminary insights
Margaret E. Kruk et al.
CLINICAL THERAPEUTICS (2006)
Yeast secretory expression of insulin precursors
T Kjeldsen
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2000)
Share Paper
